Literature DB >> 3305471

Effects of acute pressure overload on prostacyclin release and myocardial blood flow in canine hearts: inhibition of prostacyclin synthesis with 15-hydroperoxy-eicosatetraenoic acid.

M Imaizumi, Y Ito, T Ito, K Ogawa, T Satake.   

Abstract

This study was undertaken to evaluate the effects of acute pressure overload on prostacyclin (PGI2) release and the influences of 15-hydroperoxy-eicosatetraenoic acid (15-HPETE), an inhibitor of PGI2 synthetase, and indomethacin, an inhibitor of cyclo-oxygenase, in canine hearts. Gradual stenosis of the ascending aorta was performed in 24 anesthetized open-chest dogs. The mongrel dogs were divided into three groups, which received indomethacin, 15-HPETE, and no drug. Changes in the hemodynamics, regional myocardial blood flow (MBF) by the method of H2 gas clearance, and plasma immunoreactive 6-keto-prostaglandin (PG) F1 alpha level in the descending aorta (AO) and great cardiac vein (GCV) were measured. Five minutes after aortic stenosis, the plasma immunoreactive 6-keto-PGF1 alpha level in the GCV and MBF increased from 162 +/- 23 to 289 +/- 37 pg/ml and from 87 +/- 5 to 107 +/- 8 ml/min/100 g, respectively, and the calculated coronary vascular resistance (CVR) decreased significantly from 0.93 +/- 0.08 to 0.77 +/- 0.08 mmHg/ml/min/100 g. These significant changes persisted thereafter. Continuous infusion of 15-HPETE (66 pg/kg/min) into the coronary artery simultaneously prevented significant changes in MBF and the plasma immunoreactive 6-keto-PGF1 alpha level in the GCV and CVR. Intravenous infusion of indomethacin (5 mg/kg), on the other hand, induced a significant decrease in the plasma immunoreactive 6-keto-PGF1 alpha level in both the GCV and AO; significant changes in MBF 5 to 15 min after aortic stenosis and CVR were not affected. From these results, it is suggested that PGI2 plays an important role in the regulation of coronary blood flow in canine hearts with acute pressure overload.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305471     DOI: 10.1007/BF02073642

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Prostaglandins and the heart.

Authors:  M Sivakoff; E Pure; W Hsueh; P Needleman
Journal:  Fed Proc       Date:  1979-01

2.  Reactive hyperaemia in the dog heart: inter-relations between adenosine, ATP, and aminophylline and the effect of indomethacin.

Authors:  R W Giles; D E Wilcken
Journal:  Cardiovasc Res       Date:  1977-03       Impact factor: 10.787

3.  Radioimmunoassay of the F prostaglandins.

Authors:  B V Caldwell; S Burstein; W A Brock; L Speroff
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

Review 4.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

5.  Effect of 1-epinephrine on the coronary circulation in human subjects with and without coronary artery disease.

Authors:  J M Sullivan; R Gorlin
Journal:  Circ Res       Date:  1967-12       Impact factor: 17.367

6.  Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart.

Authors:  R W Alexander; K M Kent; J J Pisano; H R Keiser; T Cooper
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 7.  Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory roles in normal and abnormal circulatory systems.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prog Cardiovasc Dis       Date:  1979 May-Jun       Impact factor: 8.194

8.  Responses to prostaglandins H2 and I2 of isolated dog cerebral and peripheral arteries.

Authors:  N Toda
Journal:  Am J Physiol       Date:  1980-02

9.  Heart adaptation to acute pressure overload: an involvement of endogenous prostaglandins.

Authors:  E I Chazov; V D Pomoinetsky; N G Geling; T R Orlova; A A Nekrasova; V N Smirnov
Journal:  Circ Res       Date:  1979-08       Impact factor: 17.367

10.  Prostacyclin is not a circulating hormone.

Authors:  E Christ-Hazelhof; D H Nugteren
Journal:  Prostaglandins       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.